Loka Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 1.46 Cr
as on 10-12-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.37 Cr
as on 10-12-2024
- Revenue -23.86%
(FY 2022)
- Profit -94.48%
(FY 2022)
- Ebitda -35.25%
(FY 2022)
- Net Worth 19.71%
(FY 2022)
- Total Assets 7.99%
(FY 2022)
About Loka Biosciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.46 Cr.
The company currently has active open charges totaling ₹2.37 Cr.
Vedire Reddy and Chereddy Rammohanreddy serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC074645
- Company No.
074645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Loka Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedire Reddy  | Director | 25-May-2011 | Current |
| Chereddy Rammohanreddy | Director | 25-May-2011 | Current |
Financial Performance and Corporate Structure Insights of Loka Biosciences.
Loka Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.86% decrease. The company also saw a substantial fall in profitability, with a 94.48% decrease in profit. The company's net worth Soared by an impressive increase of 19.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Loka Biosciences?
In 2022, Loka Biosciences had a public holding of 12.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Loka Therapeutics Private LimitedActive 1 year 1 monthVedire Reddy and Chereddy Rammohanreddy are mutual person
- Vicint Biosciences Private LimitedActive 5 years 8 months
Vedire Reddy and Chereddy Rammohanreddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 30 Mar 2021 | ₹6.26 M | Open |
Axis Bank Limited Creation Date: 22 Mar 2021 | ₹7.66 M | Open |
Bank Of India Creation Date: 27 Aug 2012 | ₹9.80 M | Open |
How Many Employees Work at Loka Biosciences?
Unlock and access historical data on people associated with Loka Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Loka Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Loka Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
